Asthma pathophysiology Flashcards

1
Q

Outline the effects of LABA’s

A
Reduced bronchoconstriction 
Reduced bronchohyperactivity 
Reduced hyperplasia
Reduced inflammatory mediator release 
Reduced mucousal oedema and tissue remodeling
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Outline the effects of inhaled steroids

A
Reduced bronchohyperactivity 
Reduced inflammatory cell conc.
Reduced oedema
Reduced epithelial damage 
Reduced tissue remodeling 
Reduced cell proliferation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Why is asthma still such a problem?

A

Under diagnosed and undertreated
Misdiagnosed and mistreated
Patient compliance with treatment is poor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What factors indicate a high probability of asthma?

A
Cough + wheeze
Cough is worse at night 
Exercise induced 
Family history of asthma
Evidence of airway narrowing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

In the asthma control test, what do the scores mean?

A

Out of 25:
25: Perfectly controlled asthma
20-24: Well controlled asthma
<20: Further treatment necessary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Steps of asthma therapy

A
  1. SABA alone
  2. SABA + ICS (low) (if need for maintenance is shown)
    3.SABA + ICS (low)+ LRTA
  3. SABA+ ICS (low)+ LRTA + LABA (review LRTA effectiveness)
  4. MART (with low ICS) +/- LRTA
  5. MART (with moderate ICS) +/- LRTA
  6. MART +/- LRTA (Or high ICS on fixed dose therapy)
    Consider also LAMA and additional advice for step 7
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What does it mean to have well controlled disease?

A

The patient should suffer from no symptoms during the day and should be able to carry out their regular activities without hindrance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What lifestyle messages should you aim to get across to asthma patients?

A

Understand the risks of uncontrolled asthma

Encourage to stay active and lose weight

They should know of their lung health and personal health plan

Recommend taking vaccines

Share info with each other about meds and devices

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

BTS/SIGN vs NICE guidance

A

Main difference are the tests done and the order of the drugs given
NICE is more cost effective

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Assessing an acute exacerbation

A

ID the trigger factor
ID the type and duration of symptoms
ID the treatment started and if its working
Assess severity of exacerbation
Ask about depression, alcohol misuse, poor compliance, previous exacerbation.

Use these as a basis for deciding whether to admit to hospital

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Assessing the severity of an exacerbation

A

Check for signs of exhaustion: cyanosis, SOB
Examine patient chest and record respiratory rate, pulse an BP
Check peak expiratory flow rate:
->50-75%=moderate
-33-50%=severe
-<33%=life threatening
Measure O2 sat. if possible

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How can you manage acute exacerbations?

A

Give high O2 to maintain O2 sat at 94-98%
High dose SABA+ICS
IV Beta agonists for patient where inhalation not possible
Oral steroids in doses suitable for severity
IV magnesium sulfate for patients unresponsive to beta agonists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

The 5 steps of the BTS/SIGN guidelines

A
  1. Low dose ICS
  2. LABA + ICS (usually as MART)
  3. -If LABA doesn’t work then stop LABA and increase ICS
    - If LABA works but inadequate then increase LABA + continue ICS OR continue LABA+ICS and add LRTA
  4. Increase to high dose ICS or add 4th drug eg LAMA
  5. Add in oral steroids at lowest adequate dose
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is difficult asthma?

A

Asthma patients suffering from symptoms even on steps 4/5 of BTS/SIGN guidelines and one of:

  • life threatening exacerbation requiring invasive ventilation in the last 10 years
  • daily dose of oral steroids >7.5mg daily
  • 2 hospitilisations in last 12 months on high dose ICS
  • FEV1 <70% of normal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Questions you should ask of difficult asthma patients?

A

Do they actually have asthma?
Are there conditions that are making the asthma worse?
These include:
Bronchostasis- abnormal widening of airways causing build up of sputum and causes infection
Dysfunctional breathing
Severe COPD
Vocal chord dysfunction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How should asthma be diagnosed in the future?

A

Objective tests such as FeNOand spirometry

These are necessary due to over diagnosis based on signs and symptoms

This will take time however to build up the infrastructure necessary

17
Q

Alternative treatments for difficult asthma?

A

Anti eosinophils

Anti immunoglobulin E

Steroid sparing agents: Gold, methtrexate, ciclosporin and Terbutaline (not recommended as can be hard to stop treatment, also monitor heart rate)

18
Q

Anti-IgE (Omalizumab) indications

A

For difficult patient with: FEV1 <80% of normal
>2 severe excerabtions
+ve prick or RAST test
IgE>50 and <700 IU/ml
People outside of the weight limit and/or serum conc. for IgE should not be given Omalizumab. Usually administered to arm or thigh

19
Q

How does Omalizumab work?

A

Binds to IgE preventing binding to Mast cells
Reduces IgE bearing bronchial cells
Reduces density of IgE receptors on basophils, mast cells and APC’s
Reduces conc. of sub mucousal eosinophils

20
Q

T cell profiling

A

Patient with a higher ratio of Th2 to Th1 which is associated with higher levels of interleukins

One particular group have higher eosinophil counts and more frequent exacerbations less controlled asthma

These patients have eosinophilia promoted by IL-5. Can be treated with anti-IL-5 Mepolizumab

21
Q

Mepolizumab

A

Binds to IL-5 an interleukin which promotes eosinophil growth and activation

Reduces clinically significant exacerbations and halves no. of exacerbations requiring hospitilisations

22
Q

Indication for mepolizumab

A

For severe eosinophilic
Eosinophil count >300 cells/mcl in last 12 months
>4 exacerbations requiring oral steroids
Maintenance oral steroid dose >5mg prednisolone/day
Company provides drug at discount for patient access

23
Q

Indications for Resulizumab

A

For severe eosinphilic asthma
Eosinophil count >400 cells/mcl in last 12 months
>3 exacerbations requiring systemic steroids
Company discounts drug for patient access

24
Q

Steroid sparing agents

A

Usually immunosuppressant
Reduces the need for steroids but have significant side effects
Should be done by specialist
Only given after other treatments have proven unsuccessful

25
Q

Terbutaline Infusion

A

2.5mg/day via PICC (Peripherally inserted central catheter)

26
Q

Consequences of long term oral steroid use

A

Endocrine: Cushings syndrome, adrenal suppression
Eye: cataracts, glaucoma and papilloedema (optic disk swelling)
GI: Ulceration, pancreatitis and candidiasis
Immune: Increased chance of infection
Musculoskeletal: Myopathy, osteoporosis, fractures, growth suppression
Neurological: Makes epilepsy worse
Psychiatric: Psychosis, behavioural and cognitive disorders